Angelo Gámez‐Pozo

Author

Angelo Gámez‐Pozo

Also Known As

A F Garcia Gamez, A Gamez, A Gamez-Pozo, A Gámez, A Gámez-Pozo, A. Gamez, A. Gamez-Pozo, A. Gámez, A. Gámez-Pozo, A. G�mez

155

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Centro de Investigación Biomédica en Red de Cáncer Instituto de Salud Carlos III Hospital La Paz Institute for Health Research Universidad Nacional de Educación a Distancia

About

Angelo Gámez‐Pozo is an author at Hospital Universitario La Paz specializing in medicine, cancer research, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	403
2	Engineering	6	6	267
3	Biostatistics	3	3	47
4	Natural Sciences	2	2	68
5	Biochemistry	2	2	68

Angelo Gámez‐Pozo

Publications

945

Citations

H-Index

Page 1

	Year	Citations
PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics Angelo Gámez‐Pozo, Iker Sánchez‐Navarro, Enrique Calvo, PLoS ONE EngineeringPathologyLabel-free ProteomicsTumor BiologyProteomic Technology	2012	73
MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients Angelo Gámez‐Pozo, Luis Antón-Aparicio, Cristina Bayona, Neoplasia	2012	71
Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications Angelo Gámez‐Pozo, Julia Berges‐Soria, Jorge M. Arevalillo, Cancer Research Clinical ImplicationsUnique Metabolic ProfileEngineeringBreast OncologyGene Expression Profiling	2015	68
Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues Iker Sánchez‐Navarro, Angelo Gámez‐Pozo, Manuel González-Barón, BioTechniques Breast OncologyEngineeringMolecular BiologyPathologyGene Expression Profiling	2010	66
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses Guillermo Prado-Vázquez, Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes, Scientific Reports	2019	62
Functional proteomics outlines the complexity of breast cancer molecular subtypes Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes, Julia Berges‐Soria, Scientific Reports	2017	55
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification C. Vanesa Díaz-García, Alba Agudo-López, Carlos Pérez‐Plasencia, Carcinogenesis	2013	50
Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches Angelo Gámez‐Pozo, Iker Sánchez‐Navarro, Enrique Calvo, Molecular BioSystems Molecular BiologyTumor BiologyCancer SamplesProteomic TechnologyBioanalysis	2011	39
Metaphase arrest and cell death induced by etoposide on HeLa cells Santiago Rello‐Varona, Angelo Gámez‐Pozo, Vanessa Moreno, The International Journal of Biochemistry & Cell Biology InflammationApoptosisImmunologyCell DeathMetaphase Arrest	2006	37
Shotgun proteomics of archival triple‐negative breast cancer samples Angelo Gámez‐Pozo, Nuria Ibarz Ferrer, Eva Ciruelos, PROTEOMICS - CLINICAL APPLICATIONS	2013	36

Page 1